Advertise on podcast: All Ears Hearing and Tinnitus Podcast

Feeling foggy or drained by the end of days full of listening and conversation? Dr. Layne Garrett breaks down what's actually happening in the brain when hearing loss makes listening harder — and why that fatigue is real, even when it isn't a sign of cognitive decline. Straining to hear pulls from the same limited pool of mental energy used for memory, attention, and decision-making — a phenomenon researchers call listening effort. Dr. Garrett walks through the 2016 Eriksholm workshop's FUEL model, findings from Ear and Hearing on measurably higher listening effort in people with hearing loss, and a 2021 study showing hearing aid noise reduction processing can ease that effort in real time. He also shares the story of a patient, Mark, whose 3pm brain fog improved once his hearing aids were fitted and verified with real ear measurement — and explains why a standard hearing test alone can't answer the question of why you're exhausted by the end of the day. Dr. Garrett's practice model relies on REM-verified fittings and cognitive screening tools like Cognivue to look beyond the audiogram. Visit our Learning Center. Schedule your appointment in Utah.

Waking up with a loud ring in one ear and muffled hearing is one of the few ear situations that can't safely wait. In this episode, Dr. Layne Garrett explains sudden sensorineural hearing loss — what it is, why it's so easy to mistake for wax, sinuses, or a cold, and why the first two weeks matter so much for recovery. He breaks down why a hearing test, not a routine CT, answers the first question that counts: did the hearing in that ear actually drop? You'll hear a real patient story about waiting eleven days, what the research says about early versus delayed treatment, and a simple tiered framework for deciding how fast to move — from calling 911 for stroke signs, to same-day evaluation, to the everyday ringing that can wait. If you've searched "sudden ringing in one ear," "muffled hearing overnight," or "is sudden hearing loss an emergency," this is the clear, calm answer.

Auracast may be the biggest shift in hearing accessibility in years — but the marketing is already ahead of the reality. In this episode, Dr. Layne Garrett explains what Auracast actually does: one source (a TV, a microphone, an airport PA, a church sound system) broadcasting audio to as many listeners as want it, tapped straight from your phone into the hearing aids you already wear. No neckloop, no borrowing a receiver. He covers where it already works (the Sydney Opera House, churches and playhouses, and Frankfurt Airport as of January 2026), what it does at home for TV and microphone streaming, and why brand support varies so much that "Auracast-ready" and "Auracast-enabled" aren't the same thing. The takeaway is a single buyer's question: can this exact hearing aid receive an Auracast broadcast today, with my phone? — plus his advice to get a telecoil too. If you've searched "what is Auracast," "Auracast hearing aids," or "Auracast vs telecoil," this is the honest 2026 picture.

Red light therapy devices promise quieter tinnitus through improved circulation or calmed nerve activity — but what does the actual research say? Dr. Layne Garrett walks through three separate reviews published between 2022 and 2025 that reach different conclusions: one calls the evidence "debatable," another reads it as "generally positive," and the most recent finds short-term improvement that mostly fades within three to six months. The bigger issue isn't whether the light does anything — it's that most consumer devices sell treatment before anyone has evaluated what's actually driving the tinnitus. Dr. Garrett, founder of Timpanogos Hearing & Tinnitus and a specialist in tinnitus and complex hearing loss for more than two decades, explains why evaluation has to come first, and what actually has evidence behind it: properly fitted hearing aids, sound therapy, CBT, and Lenire bimodal neuromodulation. Learning Center — https://utahhearingaids.com/learning-center Schedule an appointment in one of Utah Clinics here.

Signia's new Charge&Go MaX arrived this fall as the boldest AI hearing aid claim of the year: four separate deep neural networks running at once and a headline figure of 97% of wearers hearing better in noisy groups. In this episode, Dr. Layne Garrett — a Doctor of Audiology with more than 20 years fitting every major manufacturer — separates the engineering from the evidence. He's worn MaX for a week and started fitting patients, and his early read is measured: excellent through a live performance, different but not clearly better in a loud lobby. He explains how to read a manufacturer's 97% claim, why the chip numbers compare to Signia's own prior IX platform rather than competitors, the Auracast feature you can't use until 2027, and why smarter automation makes real ear measurement matter more, not less. If you struggle to hear in restaurants, wonder whether AI hearing aids actually help in noise, or are weighing this year's releases, this is a grounded, medical-model take from a specialist who verifies every fitting.

"You just have to live with it" is now something the tinnitus guideline tells clinicians to avoid saying. In this episode, Dr. Layne Garrett, Au.D., FAAA, CH-TM, goes through the October 2026 update from the American Academy of Otolaryngology–Head and Neck Surgery Foundation. What we cover: - What changed since 2014 - Why a hearing evaluation is now recommended for everyone with tinnitus - The jaw and neck connection (somatosensory tinnitus) - Hearing aids, CBT, and bimodal neuromodulation (Lenire, FDA approved) - Sound therapy, from a bedside fan to a structured clinician-guided program - What the guideline recommends against - What good tinnitus care looks like in practice Visit our Online Learning Center here. You can schedule an appointment in one of clinics in Utah.

Phonak's new flagship, the Audéo EON, replaces the Infinio Sphere Ultra with a new Hypersonic chip and a retrained third-generation AI, Spheric Speech Clarity 3.0. But is it actually a better hearing aid — or the same proven performance in a smaller, more affordable package? Dr. Layne Garrett, Au.D., a Doctor of Audiology with more than 20 years fitting hearing aids across every major manufacturer, gives an honest first look based on Phonak's published materials and a full year of experience fitting Infinio Ultra. He explains why the headline AI gains are measured with the feature on versus off — not EON versus last year's flagship — and why the genuinely new story is access: flagship-level processing reaching lower price tiers. If you're searching for a Phonak EON review, wondering whether to upgrade your hearing aids, or trying to hear better in noise and restaurants, this episode helps you separate what changed from what's just repackaged. It also covers why no hearing aid works without a correct fitting, verified with real ear measurement. Learn more in our online learning center. Click here to schedule an appointment in one of our Utah clinics along the Wasatch Front.

If you've been taking ginkgo, zinc, or melatonin for your tinnitus, this episode is for you. Dr. Layne Garrett breaks down why the national clinical guideline explicitly recommends against all three — not because they're untested, but because they've been tested repeatedly and the results don't hold up. A 2022 Cochrane review of 12 trials and nearly 1,900 patients found ginkgo has little to no effect on tinnitus severity. Zinc's mechanism sounds plausible, but controlled trials show no benefit. And a 2024 meta-analysis found placebo groups improve by nearly six points on standard severity scales with no active ingredient at all — which is exactly why testimonials are so convincing and so unreliable. Dr. Garrett, founder of Timpanogos Hearing & Tinnitus and a specialist in tinnitus and complex hearing loss for more than two decades, walks through what evidence-based tinnitus care actually includes: hearing aids when hearing loss is present, CBT, sound therapy, and REM-verified fittings. Learn more in our online learning center.  Click here to schedule an appointment in one of our Utah clinics.

v]]\A new study looked at hearing loss and frailty — a geriatric measure of how much health reserve a person has left — in more than 2,600 adults over 65. Worse hearing was linked to meaningfully higher frailty scores overall, but that link nearly disappeared among people who used hearing aids. Dr. Layne Garrett, Au.D., breaks down what the research actually found, what it can't prove, and why fitting verification matters even though this particular study never measured it. Drawing on more than two decades treating tinnitus and complex hearing loss, Dr. Garrett explains why every evaluation at Timpanogos Hearing and Tinnitus includes real ear measurement — confirming exactly how much sound reaches the eardrum, rather than relying on a software prediction alone. This episode also walks through a patient story: a 78-year-old who'd quietly stopped going to his weekly cribbage game, and what changed after a properly verified fitting. Timpanogos Hearing and Tinnitus is a medical-model practice, not a transactional retailer — built around thorough, function-first care. Learning Center — https://utahhearingaids.com/learning-center

Tinnitus research headlines rarely survive the trip from a clinical trial to your feed intact — patient counts shift, disease-specific results get generalized, and animal data gets described like it's already helping people. In this episode, Dr. Layne Garrett, Au.D., breaks down four treatments actually in the tinnitus research pipeline — AC102, Auricle, and two Gateway Biotechnology programs — along with where ebselen (SPI-1005) and TMS actually stand today. He also covers the treatment already sitting on the shelf: Lenire, FDA De Novo approved since March 2023, still underused by patients who've never heard of it. Dr. Garrett has spent over two decades specializing in tinnitus and complex hearing loss at Timpanogos Hearing & Tinnitus, a medical-model practice built around Real Ear Measurement verification on every fitting and a full-time Lenire program. If you're trying to sort real relief from research that's still years away, this episode walks through what's actually proven, what's promising, and what's already available.

For years, the hard problem in hearing aids wasn't noise — it was judgment. At a crowded table, the voice you want and the voice you don't can arrive at the same volume, and the device has to guess which one matters. ReSound's new Sensia claims to make that guess better. In this first look, Dr. Layne Garrett, Au.D., explains the "loud vs. important" problem in plain language and breaks down how Sensia attacks it: an AcoustIQ classifier that reads the room, a binaural beam that works across both ears toward whoever you're facing, and a deep neural network that strips competing voices rather than just background hum. He weighs the evidence carefully — an independent German lab (Hörzentrum Oldenburg) finding better audibility of the person you face, against ReSound's own 88% classifier-accuracy figure — and shares the real patient signal that caught his attention: someone who stopped needing to touch the app at all. He's also candid about what's unproven: a quiet office is not the test, a Friday-night football game is. And he explains why none of this smart processing helps unless the fitting is verified in your ear with Real Ear Measurement. If you struggle in restaurants, church, or family gatherings, or you already wear ReSound and manage your programs manually, this is a straight, early read from the fitting chair.    Learning Center — https://utahhearingaids.com/learning-center

After two decades specializing in tinnitus, Dr. Layne Garrett shares the three lessons that changed how he evaluates every patient. A 2023 Mass Eye and Ear study found measurable auditory differences in people with completely normal hearing tests who still had chronic tinnitus — proof that a passed hearing screening doesn't mean nothing's driving the ringing. There's no single best tinnitus treatment: the national clinical guideline supports counseling, CBT, hearing aid evaluation when hearing loss is present, and sound therapy, while a 2025 single-clinic review found about nine in ten appropriately evaluated patients crossed the threshold for meaningful improvement with Lenire bimodal neuromodulation. Dr. Garrett, founder of Timpanogos Hearing & Tinnitus and holder of the CH-TM tinnitus-management credential, explains why the quality of the evaluation — not just which treatments exist — is what actually determines outcomes, and why only around a third of clinics verify hearing aid fittings with real-ear measurement. Learning Center — https://utahhearingaids.com/learning-center

Costco's hearing centers run a legitimate audiometric battery and standardized Real Ear Measurement — but they're built for fitting hearing aids, not diagnosing why someone is struggling to hear. Dr. Layne Garrett, Au.D., founder of Timpanogos Hearing & Tinnitus, walks through what a full diagnostic evaluation adds that a fitting-oriented model doesn't: tympanometry, otoacoustic emissions, and extended high-frequency audiometry above 8,000 Hz. He explains why tinnitus programming is locked out of hearing aids sold through Costco's fitting software, why hearing aids alone don't undo years of auditory struggle without structured rehabilitation, and what the 2024 Lancet Commission and ACHIEVE trial found about hearing loss and dementia risk. The episode closes with three questions every patient should ask before buying hearing aids anywhere. Click here to schedule an appointment in one of our Northern Utah Clinics. Learn More in our online learning center.

After two years as Utah's only standalone full-time Lenire provider, Dr. Layne Garrett breaks down who responds to this FDA-approved tinnitus device — and who doesn't. Two 2025 studies from real US clinical settings — published in Communications Medicine and the American Journal of Audiology — show that patients with moderate or worse tinnitus consistently see meaningful improvement after 12 weeks of Lenire. In one study of 220 qualifying patients, more than nine out of ten showed a clinically significant reduction in tinnitus burden, with an average improvement of nearly 28 points on a 100-point severity scale. Patients with mild tinnitus showed very little benefit. That distinction now drives candidacy decisions. Lenire works by pairing precisely timed audio tones through Bluetooth headphones with gentle tongue stimulation — engaging the auditory brainstem from two simultaneous directions to drive neuroplastic change. The mechanism was validated in the 2024 pivotal trial published in Nature Communications. REM-verified hearing aid fittings and structured sound therapy remain foundational; Lenire belongs in the picture when prior appropriate care hasn't provided enough relief. Candidacy turns on three factors: severity (THI 38 or above), prior treatment history, and daily adherence commitment — two 30-minute sessions for 12 weeks, every day. Dr. Garrett holds the Au.D., CH-TM, and ABAC and practices at Timpanogos Hearing & Tinnitus. Click here to schedule an appointment in one of our Utah Clinics. To learn more visit our online learning center.